Elizabeth Stewart

9PUBLICATIONS
93CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 05, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Feb 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid.

Min Pan, Yinwen Zhang, William C Wright

|Jul 26, 2024
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma.

Sara G Danielli, Yun Wei, Michael A Dyer

|Mar 28, 2024
Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF.

Sandi Radko-Juettner, Hong Yue, Jacquelyn A Myers

|Dec 06, 2021
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.

Wayne L Furman, Beth McCarville, Barry L Shulkin

|Nov 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.

Min Pan, William C Wright, Richard H Chapple

Pageof 2

Frequent Collaborators

4 joint publications

Shondra M Pruett-Miller

4 joint publications

Michael A Dyer

2 joint publications

Raymond D Carter

2 joint publications

Baranda S Hansen